Clinicoserological insights into patients with immune checkpoint inhibitor‐induced myasthenia gravis

To compare the immunopathology of immune checkpoint inhibitor‐induced myasthenia gravis (ICI‐MG) and idiopathic MG, we profiled the respective AChR autoantibody pathogenic properties. Of three ICI‐MG patients with AChR autoantibodies, only one showed complement activation and modulation/blocking pot...

Descripción completa

Detalles Bibliográficos
Autores principales: Masi, Gianvito, Pham, Minh C., Karatz, Tabitha, Oh, Sangwook, Payne, Aimee S., Nowak, Richard J., Howard, James F., Guptill, Jeffrey T., Juel, Vern C., O'Connor, Kevin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187728/
https://www.ncbi.nlm.nih.gov/pubmed/36924454
http://dx.doi.org/10.1002/acn3.51761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187728/
https://www.ncbi.nlm.nih.gov/pubmed/36924454
http://dx.doi.org/10.1002/acn3.51761

Ejemplares similares